Kingsford Pharmaceuticals

2600 Eastern Beltway

Dallas, Texas 75225
(214) 668-9234
(214) 668-2349 FAX

Release:
Feb. 12, 2015

Jake Hay
Public Relations Director
916-673-8373
jakehay94@gmail.com

KINGSFORD PHARMACEUTICALS TO ANNOUNCE WEST NILE VIRUS CURE

DALLAS, TX- Kingsford Pharmaceuticals' new medication, a tablet titled X23,
eliminates all traces of West Nile virus if taken within two weeks of first infection.
This medication is a medical brake through that will have profound implications on
human health. X23 has the potential to save thousands of lives," said CEO, Roberta Cruz-Suarez.
Before X23 may begin saving lives, it must first be approved by the Food & Drug
Administration. FDA testing is scheduled to begin within the next two weeks.
"We are confident of securing FDA approval quickly so that we can get X23 into the
hands of doctors and nurses all over the world who will partner with us in the fight against West
Nile virus, stated CEO Roberta Cruz-Suarez
###
Kingsford Pharmaceuticals was founded in 1949 and has been working continually to provide
people with quality medical products. The company distributes to 40 countries worldwide and
has served roughly 70 million people with the medical supplies they need.